Antiviral and anti-inflammatory therapies in COVID-19

被引：11

作者：

Szekanecz Zoltan ^{[1
]}

Bogos Krisztina ^{[2
]}

Constantin Tamas ^{[3
]}

Fullesdi Bela ^{[4
]}

Muller Veronika ^{[5
]}

Rakoczi Eva ^{[1
]}

Varkonyi Istvan ^{[6
]}

Valyi-Nagy Istvan ^{[7
]}

机构：

[1] Debreceni Egyet, Altalanos Orvostud Kar, Belgyogyaszati Klin, Reumatol, Debrecen, Hungary

[2] Orszagos Koranyi Pulmonol Int, Budapest, Hungary

[3] Semmelweis Egyet, Altalanos Orvostud Kar, Gyermekgyogyaszati Klin 2, Budapest, Hungary

[4] Debreceni Egyet, Altalanos Orvostud Kar, Aneszteziol & Intenz Terapias Klin, Debrecen, Hungary

[5] Semmelweis Egyet, Altalanos Orvostud Kar, Pulmonol Klin, Budapest, Hungary

[6] Debreceni Egyet, Altalanos Orvostud Kar, Infektol Klin, Debrecen, Hungary

[7] Del Pesti Ctr Korhaz, Orszagos Hematol & Infektol Int, Budapest, Hungary

来源：

ORVOSI HETILAP | 2021年 / 162卷 / 17期

关键词：

novel coronavirus infection (COVID-19); coronavirus; cytokine storm; antiviral treatment; cytokine in-hibition treatment; corticosteroid; interleukin-6; inhibition; Janus kinase inhibition; intravenous immunoglobulin; TOCILIZUMAB; MULTICENTER;

D O I：

10.1556/650.2021.32230

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The novel coronavirus infection (COVID-19) places a heavy burden on the health care system and our society. There are three major stages in the disease that fundamentally determine treatment approaches. Phases I?IIA require primarily antiviral treatment. In phases IIB?III, anti-inflammatory treatment is needed accompanied by intensive and supportive care. This recommendation applies only to pharmacotherapy and summarizes the therapeutic options based on the available evidence. It also includes a proposed treatment algorithm.

引用

页码：643 / 651

页数：9

共 50 条

[1] COVID-19: combining antiviral and anti-inflammatory treatments
Stebbing, Justin
Phelan, Anne
Griffin, Ivan
Tucker, Catherine
Oechsle, Olly
Smith, Dan
Richardson, Peter
LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 400 - 402
[2] Union is strength: antiviral and anti-inflammatory drugs for COVID-19
Naveja, Jose J.
Madariaga-Mazon, Abraham
Flores-Murrieta, Francisco
Granados-Montiel, Julio
Maradiaga-Cecena, Marco
Alaniz, Victor Duarte
Maldonado-Rodriguez, Maricruz
Garcia-Morales, Jazmin
Senosiain-Pelaez, Juan Pablo
Martinez-Mayorga, Karina
DRUG DISCOVERY TODAY, 2020, 26 (01) : 229 - 239
[3] Antibiotics with Antiviral and Anti-Inflammatory Potential Against Covid-19: A Review
Abadi, Banafshe
Ilaghi, Mehran
Shahsavani, Yasamin
Faramarzpour, Mahsa
Oghazian, Mohammad Bagher
Rahimi, Hamid-Reza
CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2023, 18 (01) : 51 - 63
[4] Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19
Khanna, Kritika
Raymond, Wilfred W.
Jin, Jing
Charbit, Annabelle R.
Gitlin, Irina
Tang, Monica
Werts, Adam D.
Barrett, Edward G.
Cox, Jason M.
Birch, Sharla M.
Martinelli, Rachel
Sperber, Hannah S.
Franz, Sergej
Duff, Thomas
Hoffmann, Markus
Healy, Anne Marie
Oscarson, Stefan
Poehlmann, Stefan
Pillai, Satish K.
Simmons, Graham
Fahy, John, V
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2022, 323 (03) : L372 - L389
[5] Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19
Portmann-Baracco, Arianna
Bryce-Alberti, Mayte
Accinelli, Roberto Alfonso
ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (12): : 831 - 831
[6] Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment
Zhao, Zhaoyan
Xiao, Yuchen
Xu, Lingqing
Liu, Ye
Jiang, Guanmin
Wang, Wei
Li, Bin
Zhu, Tianchuan
Tan, Qingqin
Tang, Lantian
Zhou, Haibo
Huang, Xi
Shan, Hong
ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (18) : 20995 - 21006
[7] Anti-inflammatory drugs in COVID-19
Elnady, Mohamed
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2021, 70 (05): : 16 - 18
[8] Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality
Imazio, Massimo
Brucato, Antonio
Lazaros, George
Andreis, Alessandro
Scarsi, Mirko
Klein, Allan
De Ferrari, Gaetano Maria
Adler, Yehuda
JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (09) : 625 - 629
[9] COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties
Muhammad Asif
Mohammad Saleem
Malik Saadullah
Hafiza Sidra Yaseen
Raghdaa Al Zarzour
Inflammopharmacology, 2020, 28 : 1153 - 1161
[10] Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in COVID-19"
Alfonso Accinelli, Roberto
Portmann-Baracco, Arianna
Bryce-Alberti, Mayte
ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (12): : 833 - 833

← 1 2 3 4 5 →